CTIS2023-506550-20-00
Recruiting
Phase 1
FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: A pilot study for a randomized clinical trial (MONITOR-PILOT)
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Metastatic breast cancer
- Sponsor
- Odense University Hospital
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women and men aged\=18 years, Diagnosis of distant relapsed MBC (biopsy\-verified) or de novo breast cancer (biopsy verification of primary tumor and disseminated disease at baseline scan), Considered eligible for first\-line systemic treatment, Considered eligible for continuous treatment monitoring by scans, Signed informed consent, Ability to read and understand Danish language
Exclusion Criteria
- •Pregnant or lactating women, Ongoing oncological treatment for another cancer, Exclusively brain metastasis, Allergy to FDG
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
sefulness of FDG-PET/CT to predict the response after anti-PD-1 antibody in patients with previously treated advanced non-small cell lung cancer: a multi-institutional studyPreviously treated advanced non-small cell lung cancerJPRN-UMIN000031009Gunma University120
Recruiting
Not Applicable
sefulness of FDG-PET/CT to predict the response after nivolumab in patients with previously treated advanced non-small cell lung cancerPreviously treated advanced non-small cell lung cancerJPRN-UMIN000020814Gunma30
Unknown
Not Applicable
sefulness of FDG-PET/CT to predict the response after pembrolizumab in patients with PD-L1 positive advanced non-small cell lung canceradvanced non-small cell lung cancerJPRN-UMIN000026730Gunma University Hospital50
Completed
Not Applicable
Early response evaluation with 18F-FDG PET/CT and immunological profiling of circulating immune cells and tumor-draining lymph nodes in non-small cell lung cancer patients treated with immunotherapy.NL-OMON48669Antoni van Leeuwenhoek Ziekenhuis50
Recruiting
Not Applicable
Comparison of findings between FDG PET/CT and FLT PET/CT in malignant tumorDigestive cancer (esophagus cancer, stomach cancer, large intestine cancer, and pancreatic carcinoma)JPRN-UMIN000005026anpuh hospital300